Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND NEW ACCOUNTING STANDARDS (Tables)

v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND NEW ACCOUNTING STANDARDS (Tables)
 6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
SCHEDULE OF ESTIMATED USEFUL LIVES

Depreciation is provided for by the straight-line method over the estimated useful lives as follows:

  

Property and Equipment   Estimated Useful Life
Scientific equipment   4-10 years
Computer equipment   3 years
Office equipment   5 years
SCHEDULE OF BASIC AND DILUTED LOSS PER SHARE

 

 

    June 30,     June 30,  
    Six months ended  
    June 30,     June 30,  
    2024     2023  
    £     £  
Net (loss) income for the period     (5,308,407 )     357,976  
Basic weighted average number of shares outstanding     64,905,328       3,030,825  
Diluted weighted average number of shares outstanding     64,905,328       3,488,575  
             
Basic (loss) income per share     (0.08 )     0.12  
Diluted (loss) income per share     (0.08 )     0.10  

Schedule of potential shares are anti-dilutive

The following potential shares are anti-dilutive and are therefore excluded from the weighted average number of shares for the purpose of diluted income per share with respect to the six months ended June 30, 2023:

Schedule of potential shares are anti-dilutive

   

Six Months Ended

June 30,

  
    2023  
    Number of Shares  
Convertible loan notes – assuming all loan notes are converted to equity     856,253  
2021 Share Option Scheme     7,934  
Warrants in issue     7,083,037  
Anti-dilutive     7,947,224